搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Everyday Health
1 小时
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
MyChesCo on MSN
3 小时
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea
The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...
24/7 Wall St
4 小时
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...
14 小时
Elon Musk upgrades to 'King Kong' of weight-loss drugs after taking Ozempic as he shares ...
Elon Musk, 53, admitted to taking Mounjaro, a drug that typically treats type-2 diabetes by lowering a person's blood sugar ...
16 小时
Looking at 2025, Health: Breakthroughs of hope and promise
Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...
头部财经
20 小时
马斯克自曝转用礼来减肥药:效果优于诺和诺德竞品,副作用更少
免责声明:本网信息来自于互联网,目的在于传递更多信息,并不代表本网赞同其观点。其内容真实性、完整性不作任何保证或承诺。如若本网有任何内容侵犯您的权益,请及时联系我们,本站将会在24小时内处理完毕。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈